MUSCLE ATROPHY
Clinical trials for MUSCLE ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MUSCLE ATROPHY trials appear
Sign up with your email to follow new studies for MUSCLE ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Protein power: new study tests if supplements can stop muscle loss in heart failure
Disease control Recruiting nowThis study looks at whether adding protein drinks to the diet can prevent muscle wasting in people with heart failure. About 120 adults with severe heart failure will be split into three groups: no extra protein, low-dose protein, or high-dose protein. Researchers will measure ch…
Matched conditions: MUSCLE ATROPHY
Phase: NA • Sponsor: Tufts Medical Center • Aim: Disease control
Last updated May 17, 2026 03:11 UTC
-
New study aims to stop muscle wasting in ICU patients
Disease control Recruiting nowThis study tests whether giving extra protein and activating muscles early can reduce muscle loss in critically ill patients in the intensive care unit (ICU). About 40 adults on breathing machines will be split into two groups: one gets standard care, the other gets extra protein…
Matched conditions: MUSCLE ATROPHY
Phase: NA • Sponsor: Technical University of Munich • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
Amino acid boost may speed muscle recovery after hip fracture in seniors
Disease control Recruiting nowThis study tests whether taking essential amino acid supplements for 4 weeks after a broken femur helps older adults rebuild muscle and reduce inflammation. Sixty people aged 65 and older with a low-energy femur fracture will be randomly assigned to either standard care or the su…
Matched conditions: MUSCLE ATROPHY
Phase: PHASE2 • Sponsor: Michael C Willey • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug trial aims to restore strength in arthritic knees
Symptom relief Recruiting nowThis early-stage study is testing the safety of a new drug called IMM01-STEM in 28 people with muscle wasting (atrophy) caused by knee osteoarthritis. The goal is to see if the drug is safe and tolerable. Participants must have moderate knee arthritis and weak thigh muscles.
Matched conditions: MUSCLE ATROPHY
Phase: PHASE1, PHASE2 • Sponsor: Immunis, Inc. • Aim: Symptom relief
Last updated May 17, 2026 02:59 UTC
-
Space muscle meltdown? flywheel workout may be the answer
Knowledge-focused Recruiting nowThis study looks at whether a specific type of exercise using a flywheel machine can help prevent muscle loss and weakness that happens when people are in space. Researchers will study 16 healthy adults who exercise regularly. They will measure muscle strength, size, and nerve si…
Matched conditions: MUSCLE ATROPHY
Phase: NA • Sponsor: Lance Bollinger • Aim: Knowledge-focused
Last updated May 17, 2026 03:08 UTC